• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

基于纳米孔的肺癌脑转移患者脑脊液中游离DNA片段化和甲基化图谱

Nanopore-based cell-free DNA fragmentation and methylation profiles from the cerebral spinal fluid of patients with lung cancer brain metastases.

作者信息

Chen Tianqi, Bai Xiangqi, Burnside Georgiana, Trinh Thy Trang Hoang, Gephart Melanie Hayden, Lau Billy T, Ji Hanlee P

机构信息

Division of Oncology, Department of Medicine, Stanford University, School of medicine, Stanford, CA, 94305, United States.

Department of Neurosurgery, Stanford University, Stanford, CA, 94305, United States.

出版信息

bioRxiv. 2025 Jul 31:2025.07.28.667300. doi: 10.1101/2025.07.28.667300.

DOI:10.1101/2025.07.28.667300
PMID:40766439
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12324296/
Abstract

BACKGROUND

Non-small cell lung cancer () patients with brain metastases () have a poor prognosis. Cerebrospinal fluid () is a source of cell free DNA () from the brain and its methylation and fragmentation properties may be an indicator of NSCLC-BMET.

METHODS

We applied a nanopore single-molecule sequencing approach to characterize the fragmentation, methylation and hydroxymethylation patterns present in CSF-derived cfDNA from NSCLC-BMET patients (N=15). We compared the cancer cfDNA finding to non-cancer healthy controls (N=11) and their CSF cfDNA. We also compared the fragmentation patterns between CSF-derived cfDNA and plasma-derived cfDNA.

RESULTS

We observed enriched mono-nucleosome levels and significantly higher mono-/trinucleosome ratios in cancer patients. Comparison with plasma-derived cfDNA further confirmed the unique fragmentation features of CSF-derived cfDNA. Distinct methylation and hydroxymethylation patterns were observed between cancer and control CSF samples. We observed significantly lower degree of hydroxymethylation in cancer patients compared to healthy controls and the affected genes had different pathway profiles.

CONCLUSIONS

CSF cfDNA in patients with NSCLC-BMET had a distinct profiles of DNA fragmentation, methylation and hydroxymethylation.

摘要

背景

伴有脑转移（BMET）的非小细胞肺癌（NSCLC）患者预后较差。脑脊液（CSF）是大脑游离DNA（cfDNA）的一个来源，其甲基化和片段化特性可能是NSCLC-BMET的一个指标。

方法

我们应用纳米孔单分子测序方法来表征NSCLC-BMET患者（N = 15）脑脊液来源的cfDNA中存在的片段化、甲基化和羟甲基化模式。我们将癌症cfDNA的发现结果与非癌症健康对照（N = 11）及其脑脊液cfDNA进行了比较。我们还比较了脑脊液来源的cfDNA和血浆来源的cfDNA之间的片段化模式。

结果

我们在癌症患者中观察到单核小体水平升高以及单核小体/三核小体比率显著更高。与血浆来源的cfDNA比较进一步证实了脑脊液来源的cfDNA独特的片段化特征。在癌症和对照脑脊液样本之间观察到了不同的甲基化和羟甲基化模式。与健康对照相比，我们在癌症患者中观察到羟甲基化程度显著更低，并且受影响的基因具有不同的通路谱。

结论

NSCLC-BMET患者的脑脊液cfDNA具有独特的DNA片段化、甲基化和羟甲基化特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab0/12324296/f0120943e79f/nihpp-2025.07.28.667300v1-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab0/12324296/6331212d2a76/nihpp-2025.07.28.667300v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab0/12324296/27ef8224f36c/nihpp-2025.07.28.667300v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab0/12324296/73f21d8f819d/nihpp-2025.07.28.667300v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab0/12324296/2615c66f679d/nihpp-2025.07.28.667300v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab0/12324296/db426f253c71/nihpp-2025.07.28.667300v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab0/12324296/9df012f0c627/nihpp-2025.07.28.667300v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab0/12324296/a2c6829c8f74/nihpp-2025.07.28.667300v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab0/12324296/37bc105a609f/nihpp-2025.07.28.667300v1-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab0/12324296/f0120943e79f/nihpp-2025.07.28.667300v1-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab0/12324296/6331212d2a76/nihpp-2025.07.28.667300v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab0/12324296/27ef8224f36c/nihpp-2025.07.28.667300v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab0/12324296/73f21d8f819d/nihpp-2025.07.28.667300v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab0/12324296/2615c66f679d/nihpp-2025.07.28.667300v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab0/12324296/db426f253c71/nihpp-2025.07.28.667300v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab0/12324296/9df012f0c627/nihpp-2025.07.28.667300v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab0/12324296/a2c6829c8f74/nihpp-2025.07.28.667300v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab0/12324296/37bc105a609f/nihpp-2025.07.28.667300v1-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aab0/12324296/f0120943e79f/nihpp-2025.07.28.667300v1-f0009.jpg

相似文献

1
Nanopore-based cell-free DNA fragmentation and methylation profiles from the cerebral spinal fluid of patients with lung cancer brain metastases.基于纳米孔的肺癌脑转移患者脑脊液中游离DNA片段化和甲基化图谱
bioRxiv. 2025 Jul 31:2025.07.28.667300. doi: 10.1101/2025.07.28.667300.
2
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA？一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
3
Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028).动态监测脑脊液循环肿瘤 DNA，以鉴定脑转移瘤的独特遗传特征，并更好地预测脑转移的非小细胞肺癌患者颅内肿瘤的反应：一项前瞻性队列研究（GASTO 1028）。
BMC Med. 2022 Nov 14;20(1):398. doi: 10.1186/s12916-022-02595-8.
4
Characterization of methylation profile in biofluid cell-free DNA and identification of differentially methylated genes for phenotypic representations in Parkinson's disease.生物体液游离DNA甲基化谱的表征及帕金森病表型表现中差异甲基化基因的鉴定。
Clin Neurol Neurosurg. 2025 Sep;256:109014. doi: 10.1016/j.clineuro.2025.109014. Epub 2025 Jun 10.
5
A nanowire-based liquid biopsy method using cerebrospinal fluid cell-free DNA for targeted management of leptomeningeal carcinomatosis.基于纳米线的液体活检方法，利用脑脊液无细胞 DNA 进行脑膜癌病的靶向管理。
J Cancer Res Clin Oncol. 2021 Jan;147(1):213-222. doi: 10.1007/s00432-020-03324-5. Epub 2020 Jul 23.
6
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍（MCI）患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
7
Dissecting cell-free DNA fragmentation variation in tumors using cell line-derived xenograft mouse.利用细胞系衍生的异种移植小鼠剖析肿瘤中游离DNA的片段化变异
PLoS One. 2025 Jul 15;20(7):e0327483. doi: 10.1371/journal.pone.0327483. eCollection 2025.
8
Detection of diagnostic somatic copy number alterations from cerebrospinal fluid cell-free DNA in brain tumor patients.从脑肿瘤患者的脑脊液游离 DNA 中检测诊断性体细胞拷贝数改变。
Acta Neuropathol Commun. 2024 Nov 20;12(1):177. doi: 10.1186/s40478-024-01887-9.
9
The status of WIF1 methylation in cell-free DNA is associated with the insusceptibility for gefitinib in the treatment of lung cancer.游离 DNA 中 WIF1 甲基化状态与肺癌患者对吉非替尼治疗的耐药性相关。
J Cancer Res Clin Oncol. 2021 Aug;147(8):2239-2248. doi: 10.1007/s00432-021-03640-4. Epub 2021 May 26.
10
Cell-free DNA profiles of dermatomyositis and its potential role in discriminating phenotypes.皮肌炎的游离DNA图谱及其在区分表型中的潜在作用。
Front Immunol. 2025 Jun 17;16:1605121. doi: 10.3389/fimmu.2025.1605121. eCollection 2025.

本文引用的文献

1
TFAP2A drives non-small cell lung cancer (NSCLC) progression and resistance to targeted therapy by facilitating the ESR2-mediated MAPK pathway.TFAP2A通过促进ESR2介导的MAPK信号通路，驱动非小细胞肺癌（NSCLC）进展并导致对靶向治疗耐药。
Cell Death Discov. 2024 Dec 18;10(1):491. doi: 10.1038/s41420-024-02251-5.
2
The path to leptomeningeal metastasis.脑膜转移途径。
Nat Rev Cancer. 2024 Jul;24(7):448-460. doi: 10.1038/s41568-024-00700-y. Epub 2024 Jun 13.
3
Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases.
驱动基因突变型非小细胞肺癌合并脑转移患者的治疗结局和预后因素。
Sci Rep. 2024 Mar 9;14(1):5820. doi: 10.1038/s41598-024-56046-w.
4
Detecting DNA hydroxymethylation: exploring its role in genome regulation.检测 DNA 羟甲基化：探索其在基因组调控中的作用。
BMB Rep. 2024 Mar;57(3):135-142. doi: 10.5483/BMBRep.2023-0250.
5
ELK1/MTOR/S6K1 Pathway Contributes to Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer.ELK1/MTOR/S6K1 通路促进非小细胞肺癌对吉非替尼的获得性耐药。
Int J Mol Sci. 2024 Feb 17;25(4):2382. doi: 10.3390/ijms25042382.
6
Oncogenic alterations in advanced NSCLC: a molecular super-highway.晚期非小细胞肺癌中的致癌改变：一条分子高速公路。
Biomark Res. 2024 Feb 12;12(1):24. doi: 10.1186/s40364-024-00566-0.
7
Plasma cell-free DNA hydroxymethylation profiling reveals anti-PD-1 treatment response and resistance biology in non-small cell lung cancer.血浆无细胞游离 DNA 羟甲基化分析揭示了非小细胞肺癌抗 PD-1 治疗反应和耐药生物学。
J Immunother Cancer. 2024 Jan 11;12(1):e008028. doi: 10.1136/jitc-2023-008028.
8
Identification of ATAD3A as a key regulator in non-small cell lung cancer by promoting STAT3-induced cell proliferation and tumor angiogenesis.鉴定 ATAD3A 为非小细胞肺癌的关键调节因子，通过促进 STAT3 诱导的细胞增殖和肿瘤血管生成。
Mol Carcinog. 2024 Mar;63(3):510-523. doi: 10.1002/mc.23667. Epub 2023 Dec 5.
9
Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencing.利用纳米孔测序技术实时分析血浆和尿液无细胞 DNA 中的癌症基因组和片段组。
EMBO Mol Med. 2023 Dec 7;15(12):e17282. doi: 10.15252/emmm.202217282. Epub 2023 Nov 9.
10
Single-molecule methylation profiles of cell-free DNA in cancer with nanopore sequencing.基于纳米孔测序的游离 DNA 单分子甲基化谱在癌症中的研究。
Genome Med. 2023 May 3;15(1):33. doi: 10.1186/s13073-023-01178-3.